United States · 
What does Bain Capital Life Sciences invest in?
Bain Capital Life Sciences invests most often at Series A and Series B (57% of the rounds on record), in sectors such as Pharmaceuticals, Biotechnology and Medical Devices.
Bain Capital Life Sciences highlights
- 01
15 cheques in the last 12 months
- 02
Mostly Series A and Series B: 57% of its rounds
- 03
Led 5 rounds
What they do
We target four types of investment opportunities: Inflection Capital, Growth Capital, Fallen Angels, and Larger Private Equity Collaborations and New Company Formation.From their own website
- Type
- Private equity (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- PharmaceuticalsBiotechnologyMedical Devices
- Based in
- Boston, United States
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first49 appearances
- 2026
11 rounds
- Oct
- Oct
- Jul
- Jun
- May
- May
- May
- Mar
- Mar
- Feb
- Jan
- 2025
15 rounds
- Dec
- Dec
- Dec
- Nov
- Oct
- Oct
- Oct
- Sept
- Aug
- Apr
- Apr
- Mar
- Jan
- Jan
- Jan
- 2024
6 rounds
- Dec
- Nov
- Sept
- Jul
- May
- Feb
- 2023
6 rounds
- Dec
- Nov
- Oct
- Jun
- Jun
- Feb
- 2022
3 rounds
- Nov
- Nov
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration4 named
AKAdam KoppelExecutive OfficeriFiling they signed
AHAndrew HackExecutive OfficeriFiling they signed
JSJeffrey SchwartzExecutive OfficeriFiling they signed
RSRicky SunExecutive OfficeriFiling they signed
We also hold 14 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
4+funds on filenumbered funds in its name
What they claim to have backed
From their own portfolio page (on their website)
0 of 9 we have independently watched raise
CreditDouble ImpactInsuranceJapan - 日本LOCATIONSPrivate EquityReal EstateSpecial SituationsTech Opportunities
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.